Marco Maria D’Andrea

Researcher in Microbiology

Department of Biology
Laboratory of Microbiology

Tel. 06-7259-4021








Latest publications

  • 2020 – DNABII targeting antibodies as vaccines against biofilm diseases – EBioMedicine – 10.1016/j.ebiom.2020.102921
  • 2020 – Characterization of vb_stus_mmda13, a newly discovered bacteriophage infecting the agar-degrading species sphingomonas turrisvirgatae – Viruses10.3390/v12080894
  • 2020 – Determination of the capsular polysaccharide structure of the Klebsiella pneumoniae ST512 representative strain KPB-1 and assignments of the glycosyltransferases functions – International Journal of Biological Macromolecules10.1016/j.ijbiomac.2020.03.196
  • 2020 – The lytic bacteriophage vB_EfaH_EF1TV, a new member of the Herelleviridae family, disrupts biofilm produced by Enterococcus faecalis clinical strains – Journal of Global Antimicrobial Resistance10.1016/j.jgar.2019.10.019
  • 2020 – Abundance of Colistin-Resistant, OXA-23- and ArmA-Producing Acinetobacter baumannii Belonging to International Clone 2 in Greece – Frontiers in Microbiology10.3389/fmicb.2020.00668
  • 2020 – Genomic Epidemiology of Carbapenem- and Colistin-Resistant Klebsiella pneumoniae Isolates From Serbia: Predominance of ST101 Strains Carrying a Novel OXA-48 Plasmid – Frontiers in Microbiology10.3389/fmicb.2020.00294
  • 2019 – The urgent need for novel antimicrobial agents and strategies to fight antibiotic resistance – Antibiotics10.3390/antibiotics8040254
  • 2019 – Structure of the capsular polysaccharide of the KPC-2-producing Klebsiella pneumoniae strain KK207-2 and assignment of the glycosyltransferases functions – International Journal of Biological Macromolecules10.1016/j.ijbiomac.2019.02.128
  • 2019 – Characterization of Tn6349, a novel mosaic transposon carrying poxtA, cfr and other resistance determinants, inserted in the chromosome of an ST5-MRSA-II strain of clinical origin – Journal of Antimicrobial Chemotherapy10.1093/jac/dkz278
  • 2019 – Nasopharingeal bacterial and fungal colonization in HIV-positive versus HIV-negative adults – New Microbiologica
  • 2018 – Sphingomonas turrisvirgatae sp. nov., an agar-degrading species isolated from freshwater – International Journal of Systematic and Evolutionary Microbiology10.1099/ijsem.0.002896
  • 2018 – Characterization of poxtA, a novel phenicol-oxazolidinone-tetracycline resistance gene from an MRSA of clinical origin – Journal of Antimicrobial Chemotherapy10.1093/jac/dky088
  • 2018 – Characterization of a multiresistance plasmid carrying the optra and Cfr resistance genes from an enterococcus faecium clinical isolate – Frontiers in Microbiology10.3389/fmicb.2018.02189
  • 2018 – Italian nationwide survey on pseudomonas aeruginosa from invasive infections: Activity of ceftolozane/tazobactam and comparators, and molecular epidemiology of carbapenemase producers – Journal of Antimicrobial Chemotherapy10.1093/jac/dkx453
  • 2018 – Evaluation of the KPC K-SeT™ immunochromatographic assay for the rapid detection of KPC carbapenemase producers from positive blood cultures – Journal of Antimicrobial Chemotherapy10.1093/jac/dkx406
  • 2018 – The interplay of diagnostic and antimicrobial stewardship for the management of septic patients: The Tuscan model – Recenti Progressi in Medicina10.1701/2865.28909
  • 2018 – Characterization of vB_Kpn_F48, a newly discovered lytic bacteriophage for Klebsiella pneumoniae of sequence type 101 – Viruses10.3390/v10090482
  • 2017 – φbO1E, a newly discovered lytic bacteriophage targeting carbapenemase-producing Klebsiella pneumoniae of the pandemic Clonal Group 258 clade II lineage – Scientific Reports10.1038/s41598-017-02788-9
  • 2017 – Infections caused by carbapenem-resistant Klebsiella pneumoniae with hypermucoviscous phenotype: A case report and literature review – Virulence10.1080/21505594.2017.1286439
  • 2017 – pHTβ-promoted mobilization of non-conjugative resistance plasmids from Enterococcus faecium to Enterococcus faecalis – Journal of Antimicrobial Chemotherapy10.1093/jac/dkx197
  • 2017 – Differential Th17 response induced by the two clades of the pandemic ST258 Klebsiella pneumoniae clonal lineages producing KPC-type carbapenemase – PLoS ONE10.1371/journal.pone.0178847
  • 2017 – Draft genome sequence of the agarase-producing Sphingomonas sp. MCT13 – Frontiers in Environmental Science10.3389/fenvs.2017.00009
  • 2017 – Plasmid-mediated or chromosomally mediated colistin resistance in Klebsiella pneumoniae? – The Lancet Infectious Diseases10.1016/S1473-3099(16)30552-7
  • 2017 – Differences in Inflammatory Response Induced by Two Representatives of Clades of the Pandemic ST258 Klebsiella pneumoniae Clonal Lineage Producing KPC-Type Carbapenemases – PLoS ONE10.1371/journal.pone.0170125
  • 2016 – Molecular epidemiology of KPC-producing Klebsiella pneumoniae from invasive infections in Italy: Increasing diversity with predominance of the ST512 clade II sublineage – Journal of Antimicrobial Chemotherapy10.1093/jac/dkw337
  • 2016 – Linezolid-resistant cfr-positive MRSA, Italy – Journal of Antimicrobial Chemotherapy10.1093/jac/dkw108
  • 2016 – First case of bacteremic liver abscess caused by an ST260-related (ST1861), hypervirulent Klebsiella pneumoniae – Journal of Infection10.1016/j.jinf.2016.04.006
  • 2016 – Colistin resistance caused by inactivation of the MgrB regulator is not associated with decreased virulence of sequence type 258 KPC carbapenemase-producing Klebsiella pneumoniae – Antimicrobial Agents and Chemotherapy10.1128/AAC.02981-15
  • 2016 – Draft genome sequence of Proteus mirabilis NO-051/ 03, representative of a multidrug-resistant clone spreading in Europe and expressing the CMY-16 AmpC-type β-lactamase – Genome Announcements10.1128/genomeA.01702-15
  • 2016 – Complete genome sequence of the first KPC-type carbapenemase-positive Proteus mirabilis strain from a bloodstream infection – Genome Announcements10.1128/genomeA.00607-16
  • 2016 – Newborn bacteraemia caused by an Aeromonas caviae producing the VIM-1 and SHV-12 β-lactamases, encoded by a transferable plasmid – Journal of Antimicrobial Chemotherapy10.1093/jac/dkv304